Comparable Postthaw CD34+ and CD3+ Cell Characteristics With Commercial and In-House Cryoprotectants: Commercial Favored for Ease of Use

Kakon, N., Luizaga, H., Pham, C., Bezabih, R., Elnour, H., Procter, J., Ping, J., Highfill, S., Stroncek, D. F., Panc, S. R.   Comparable Postthaw CD34+ and CD3+ Cell Characteristics With Commercial and In-House Cryoprotectants: Commercial Favored for Ease of Use.  Transfusion. 2019; 59(S3), 106A-107A.  doi:10.1111/trf.15462

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.